Triglyceride–cholesterol–body weight index and incident cardiovascular disease in cardiovascular-kidney-metabolic syndrome stages 0–3: a CHARLS cohort study
Higher baseline and cumulative TCBI were associated with greater CVD risk among adults with CKM stages 0–3, suggesting that repeated TCBI assessment may add information for risk stratification.
Abstract
The triglyceride-cholesterol-body weight index (TCBI) integrates serum triglycerides, total cholesterol, and body weight in a single nutritional-metabolic measure. Using data from the China Health and Retirement Longitudinal Study (CHARLS), we examined whether TCBI was associated with incident cardiovascular disease (CVD) among middle-aged and older Chinese adults classified into cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3. The prospective analysis included 8,030 participants; cumulative-exposure and pattern analyses used a landmark cohort of 4,583 participants. In fully adjusted Cox models, each one-unit increase in log-TCBI was associated with a 15% higher CVD hazard (HR 1.15, 95% CI 1.07–1.23) at baseline and an 8% higher hazard (HR 1.08, 95% CI 1.04–1.13) for cumulative exposure; both dose–response relationships were nonlinear. K-means clustering separated participants into persistently high, moderate, and low groups; the low group had less CVD than the high group (HR 0.69, 95% CI 0.59–0.82, P < 0.001). Findings were consistent in Fine-Gray competing-risk and sensitivity analyses. Higher baseline and cumulative TCBI were associated with greater CVD risk among adults with CKM stages 0–3, suggesting that repeated TCBI assessment may add information for risk stratification.
Background The triglyceride–cholesterol–body weight index (TCBI) is a simple composite nutritional marker. However, its association with incident diabetes remains unclear. We examined this association in Chinese adults, focusing on non-linear and threshold effects. Methods This retrospective cohort study included 206,0...
Xue Guo, Yao-Liang Wu, Guang-Qin Ren et al.· Frontiers in Nutrition· 0 citations
The triglyceride-glucose-HDL-BMI (TyHGB) index combines triglycerides, HDL cholesterol, fasting glucose and BMI, which overlap with components used in cardiovascular-kidney-metabolic (CKM) staging. We examined its cross-sectional association with advanced CKM syndrome in two population-based cohorts.
We anal...
Jian Liu, Chan-Juan Luo, L. Liu et al.· Journal of the Renin-Angiote...· 0 citations
Cardiovascular-kidney-metabolic (CKM) syndrome encompasses interrelated cardiovascular, renal and metabolic disorders. Arthritis is linked to CKM multimorbidity, but the association between triglyceride-glucose body mass index (TyG-BMI), a surrogate marker of insulin resistance and incident arthritis across the CKM spe...
Hao-Kun Yan, Yao Yang, Bai-Xiao Zhao· Medicine· 0 citations
Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...
Jiabaili Wang, Qian Liu, Meng-Hui Li et al.· Frontiers in Endocrinology· 0 citations
Background The American Heart Association (AHA) introduced the Cardiovascular-Kidney-Metabolic (CKM) syndrome framework, emphasizing the interplay of metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD). Whether the metabolic syndrome (MetS) score—a simple count of metabolic abnormalities—pr...
Li-Xin Cao, Dan Luo, Shuang Liu et al.· Metabolism Open· 0 citations